Results 141 to 150 of about 110,459 (310)
Abstract Purpose To investigate the association between best‐corrected visual acuity (BCVA) and quantitative macular fluid volumes, compared to central subfield thickness (CST) in treatment‐naïve and previously treated patients with active neovascular age‐related macular degeneration (nAMD).
Anna Eidenberger +15 more
wiley +1 more source
Low‐contrast visual acuity versus low‐luminance visual acuity in choroideremia
Clinical relevance Choroideremia is a progressive X‐linked inherited rod‐cone dystrophy. Patients present with nyctalopia and progressive visual field loss, but visual acuity remains well preserved early on. This study showed that low‐luminance visual acuity may be a useful clinical outcome measure during earlier disease stages.
Laura J Wood +6 more
wiley +1 more source
Retinal Degeneration in Alzheimer's Disease 5xFAD Mice Fed DHA-Enriched Diets. [PDF]
Pinho MS +7 more
europepmc +1 more source
Abstract Purpose To define the curriculum content for two interactive learning courses on age‐related macular degeneration (AMD): (1) an advanced course tailored for general ophthalmologists and (2) a basic course for non‐ophthalmologist healthcare staff.
Filip Sommer‐Lind +46 more
wiley +1 more source
Abstract Purpose This study evaluates whether mesopic microperimetry (MMP) provides a more robust measure of retinal function compared to visual acuity (VA) in age‐related macular degeneration (AMD) clinical trials, with a focus on optimal analysis strategies. Method Fellow‐eyes of unilateral neovascular AMD were prospectively studied.
Francesco Cinque +9 more
wiley +1 more source
Glucose-Powered Ultrasmall Chemotactic Nanorobots for Retinal Degeneration Treatment. [PDF]
Ju X +4 more
europepmc +1 more source
Neovascular age‐related macular degeneration without drusen
Abstract Purpose To describe the clinical characteristics and 1‐year follow‐up of patients with neovascular AMD (nAMD) without drusen in either eye. Methods This is a multicentre retrospective cohort study in three tertiary referral centres in The Netherlands. We included patients of 55 years or older with nAMD in one or both eyes, without the presence
Marc J. Sirks +9 more
wiley +1 more source

